Publications
Download CSV
Download XLSX
Download TXT
Tables
2024 (245)
2023 (884)
2022 (828)
2021 (891)
2020 (640)
2019 (727)
2018 (651)
2017 (681)
2016 (664)
2015 (429)
2014 (376)
2013 (319)
2012 (245)
2011 (163)
2010 (139)
All (7882)
Infrastructure Units
Infrastructure Units list
Infrastructure Units table
Researchers
Subset
Documentation
About
Contact
Software
Login
Govender T
JSON
CSV
XLSX
TXT
Family name
Govender
Given name
Thavendran
Initials
T
ORCID
ORCID
0000-0003-2511-2503
Affiliations
Catalysis and Peptide Research Unit
University of KwaZulu Natal
Durban
South Africa
5 publications
DOI
Crossref
N-Arylation of primary and tertiary sulfonimidamides (SIAs) with benzyne precursors under transition metal-free conditions
Ambala S, Govender KB, Rajbongshi KK, ...,
Naicker T
, Arvidsson PI
Tetrahedron Letters
124
(-) 154583 [2023-07-00; online 2023-07-00]
Drug Discovery and Development (DDD) [Technology development]
PubMed
DOI
Crossref
Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel β-Lactam-Metallo-β-Lactamase Inhibitors.
Reddy N,
Girdhari L
, Shungube M, ...,
Govender T
,
Naicker T
Antibiotics (Basel)
12
(4) - [2023-03-23; online 2023-03-23]
Drug Discovery and Development (DDD) [Collaborative]
PubMed
DOI
Crossref
In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales.
Peters BK
, Reddy N, Shungube M, ...,
Naicker T
,
Govender T
ACS Infect Dis
9
(3) 486-496 [2023-03-10; online 2023-02-14]
Drug Discovery and Development (DDD) [Collaborative]
DOI
Crossref
Organic Base-Mediated Carboxylation of (Hetero)aromatic Compounds Using Supercritical Carbon Dioxide (scCO2)
Govender T
,
Chetty LC
,
Kruger HG
,
Arvidsson PI
,
Naicker T
Synthesis
54
(21) 4827-4833 [2022-11-00; online 2022-08-16]
Drug Discovery and Development (DDD) [Collaborative]
DOI
Crossref
Synthesis of novel 1,2,4-thiadiazinane 1,1-dioxides via three component SuFEx type reaction
Khumalo MF,
Akpan ED
,
Chinthakindi PK
, ...,
Naicker T
,
Arvidsson PI
RSC Adv.
8
(65) 37503-37507 [2018-00-00; online 2018-00-00]
Drug Discovery and Development (DDD) [Technology development]
SciLifeLab Data Centre
Publications
9.5.0